OVID · Company research
Ovid Therapeutics Inc. Common Stock (OVID): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Ovid Therapeutics (NasdaqCM:OVID) Stock Forecast & Analyst Predictions - Simply Wall Street | Ovid Therapeutics (NasdaqCM:OVID) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 9, 2026 | neutral | 0 | 0.6 |
| Ovid Therapeutics (OVID) Stock Gets Fair Value Boost As Analysts Focus On OV329 - Yahoo Finance | Ovid Therapeutics (OVID) Stock Gets Fair Value Boost As Analysts Focus On OV329 Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| Ovid Therapeutics (OVID) insider prepares new stock sale after recent August trades - Stock Titan | Ovid Therapeutics (OVID) insider prepares new stock sale after recent August trades Stock Titan | View source ↗ | Stock Titan | Aug 24, 2026 | neutral | 0 | 0.6 |
| What Makes Ovid Therapeutics (OVID) a Strong Momentum Stock: Buy Now? - Yahoo Finance | What Makes Ovid Therapeutics (OVID) a Strong Momentum Stock: Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 18, 2026 | neutral | 0 | 0.6 |
| Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results - GlobeNewswire | Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results GlobeNewswire | View source ↗ | GlobeNewswire | Aug 13, 2026 | neutral | 0 | 0.6 |
| Ovid Therapeutics earnings beat by $0.04, revenue topped estimates - Investing.com | Ovid Therapeutics earnings beat by $0.04, revenue topped estimates Investing.com | View source ↗ | Investing.com | Aug 13, 2026 | neutral | 0 | 0.6 |
| Ovid Therapeutics: Risk-Adjusted Valuation Shows Deep Discount Despite 700% Rally - Seeking Alpha | Ovid Therapeutics: Risk-Adjusted Valuation Shows Deep Discount Despite 700% Rally Seeking Alpha | View source ↗ | Seeking Alpha | Jul 7, 2026 | neutral | 0 | 0.6 |
| OVID Forecast — Price Target — Prediction for 2027 - TradingView | OVID Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| $OVID stock is up 9% today. Here's what we see in our data. | OVID Stock News - Quiver Quantitative | $OVID stock is up 9% today. Here's what we see in our data. | OVID Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 7, 2026 | neutral | 0 | 0.6 |
| Investors pour $60M into Ovid Therapeutics to advance seizure drugs - Crain's New York | Investors pour $60M into Ovid Therapeutics to advance seizure drugs Crain's New York | View source ↗ | Crain's New York | Mar 25, 2026 | neutral | 0 | 0.6 |
| Here's Why Ovid Therapeutics Stock Popped Higher Today - The Motley Fool | Here's Why Ovid Therapeutics Stock Popped Higher Today The Motley Fool | View source ↗ | The Motley Fool | Mar 18, 2026 | neutral | 0 | 0.6 |
| Ovid Therapeutics Inc. Common Stock (OVID) Stock Price: Oct 9 Close $2.46 - Gotrade | Ovid Therapeutics Inc. Common Stock (OVID) Stock Price: Oct 9 Close $2.46 Gotrade | View source ↗ | Gotrade | Mar 11, 2026 | neutral | 0 | 0.6 |
| $OVID stock is up 12% today. Here's what we see in our data. | OVID Stock News - Quiver Quantitative | $OVID stock is up 12% today. Here's what we see in our data. | OVID Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Mar 9, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 31, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.